ARA 290 vs HMG (Human Menopausal Gonadotropin)
Updated July 27, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of ARA 290 and HMG (Human Menopausal Gonadotropin) (also searched as HMG (Human Menopausal Gonadotropin) vs ARA 290) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
ARA 290 centers on healing, while HMG (Human Menopausal Gonadotropin) leans toward healing. On indexed research, HMG (Human Menopausal Gonadotropin) is ahead (ARA 290: 13 studies, Human evidence; HMG (Human Menopausal Gonadotropin): 17, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •ARA 290 is strongest for healing; HMG (Human Menopausal Gonadotropin) for healing.
- •Evidence: ARA 290 Human evidence (13 studies) vs HMG (Human Menopausal Gonadotropin) Human evidence (17).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
Tissue-Protective Peptide | Innate Repair Receptor Agonist
Human Menopausal Gonadotropin | FSH/LH Fertility Hormone
ARA 290 vs HMG (Human Menopausal Gonadotropin): side-by-side
| Metric | ARA 290 | HMG (Human Menopausal Gonadotropin) |
|---|---|---|
| Class | Healing | Sexual Health |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Human evidence | Human evidence |
| Studies indexed | 13 | 17 |
| Research level | Extensively Studied | Extensively Studied |
| Strongest effect | Healing & recovery | Healing & recovery |
| Healing & recovery | 4.0▲ | 2.0 |
| Muscle & body comp | 0.0 | 0.0 |
| Metabolic & appetite | 0.0 | 0.0 |
| Neuro & mood | 4.0▲ | 0.0 |
| Sleep & circadian | 0.0 | 0.0 |
| Inflammation & immune | 3.0▲ | 0.0 |
| Skin & aesthetics | 0.0 | 0.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | ARA 290 | HMG (Human Menopausal Gonadotropin) |
|---|---|---|
| Mechanism | β-common receptor interaction | FSH and LH receptor agonist |
| Route | — | Subcutaneous injection |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is HMG (Human Menopausal Gonadotropin)?
HMG (Human Menopausal Gonadotropin) is a urine-derived injectable containing FSH and LH activity, used clinically to drive ovulation in IVF cycles and restore spermatogenesis in hypogonadotropic men.
Full HMG (Human Menopausal Gonadotropin) profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | ARA 290 | 4.0/5 effect signal |
| Neuro | ARA 290 | 4.0/5 effect signal |
| Inflammation | ARA 290 | 3.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack ARA 290 and HMG (Human Menopausal Gonadotropin)?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
ARA 290 vs HMG (Human Menopausal Gonadotropin): side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
ARA 290 has 13 approved studies indexed (Human evidence), and HMG (Human Menopausal Gonadotropin) has 17 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is ARA 290 or HMG (Human Menopausal Gonadotropin) better?
It depends on your goal. ARA 290 is strongest for healing; HMG (Human Menopausal Gonadotropin) for healing. HMG (Human Menopausal Gonadotropin) has more indexed studies (17). See the goal-by-goal breakdown above.
Which has more research, ARA 290 or HMG (Human Menopausal Gonadotropin)?
ARA 290 has 13 approved studies indexed (Human evidence); HMG (Human Menopausal Gonadotropin) has 17 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack ARA 290 and HMG (Human Menopausal Gonadotropin)?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of ARA 290 vs HMG (Human Menopausal Gonadotropin)?
ARA 290: no community-reported effects logged yet. HMG (Human Menopausal Gonadotropin): none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is ARA 290 or HMG (Human Menopausal Gonadotropin) FDA-approved?
ARA 290 is a research-use compound and is not FDA-approved. HMG (Human Menopausal Gonadotropin) is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is HMG (Human Menopausal Gonadotropin) better than ARA 290?
For healing, HMG (Human Menopausal Gonadotropin) has the edge; for healing, ARA 290 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
ARA 290 and HMG (Human Menopausal Gonadotropin) are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 27, 2026.